These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7482812)

  • 1. Prophylactic cytomegalovirus management strategies.
    Martin M
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):23-7. PubMed ID: 7482812
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of combination prophylaxis with cytomegalovirus hyperimmune globulin and acyclovir in the high-risk kidney transplant recipient.
    Uber L; Cofer J; Baliga P; Rajagopalan PR
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):42-3. PubMed ID: 7482818
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategies for the prevention of cytomegalovirus infection and disease in pediatric liver transplantation recipients.
    Campbell AL; Herold BC
    Pediatr Transplant; 2004 Dec; 8(6):619-27. PubMed ID: 15598337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune globulin (GAMMAGARD) prophylaxis of CMV infections in patients undergoing organ transplantation and allogeneic bone marrow transplantation.
    Fehir KM; Decker WA; Samo T; Young JB; Lederer E; Lawrence EC
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3107-9. PubMed ID: 2539691
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytomegalovirus after heart transplantation: definitions for the guidance of antiviral therapy.
    Iberer F; Tscheliessnigg K; Halwachs G; Auer T; Wasler A; Petutschnigg B; Schreier G; Müller H; Allmayer T; Prenner G
    Scand J Infect Dis Suppl; 1995; 99():100-3. PubMed ID: 8668929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus infection in kidney transplantation: prophylaxis and management.
    Bulinski P; Toledo-Pereyra LH; Dalal S; Hernandez G
    Transplant Proc; 1996 Dec; 28(6):3310-1. PubMed ID: 8962286
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiviral antibodies in transplantation.
    Snydman DR
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):10-2. PubMed ID: 7482809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and treatment of cytomegalovirus disease in thoracic organ transplant patients: evidence for a beneficial effect of hyperimmune globulin.
    Valantine HA
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):49-57. PubMed ID: 7482821
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytomegalovirus hyperimmune globulin for CMV disease refractory to ganciclovir in renal transplantation.
    Waid TH; McKeown JW
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):46. PubMed ID: 7482820
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytomegalovirus prophylaxis with ganciclovir, acyclovir, and CMV hyperimmune globulin in liver transplant patients receiving OKT3 induction.
    Ham JM; Shelden SL; Godkin RR; Posner MP; Fisher RA
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):31-3. PubMed ID: 7482814
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined antiviral and immunoglobulin therapy as prophylaxis against cytomegalovirus infection after heart transplantation.
    Valenza M; Czer LS; Pan SH; Aleksic I; Freimark D; Harasty DA; Admon D; Barath P; Blanche C; Trento A
    J Heart Lung Transplant; 1995; 14(4):659-65. PubMed ID: 7578172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation.
    Sarmiento E; Lanio N; Gallego A; Rodriguez-Molina J; Navarro J; Fernandez-Yañez J; Palomo J; Rodríguez-Hernández C; Ruiz M; Alonso R; Fernandez-Cruz E; Carbone J
    Int Immunopharmacol; 2009 Jun; 9(6):649-52. PubMed ID: 18940269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic immunoglobulin therapy improves the outcome of renal transplantation in recipients at risk for primary cytomegalovirus disease.
    Conti DJ; Freed BM; Lempert N
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1421-2. PubMed ID: 8382867
    [No Abstract]   [Full Text] [Related]  

  • 14. Effective strategies to prevent cytomegalovirus disease after renal transplantation.
    Chapman JR
    Transplant Proc; 2000 Nov; 32(7):1508-9. PubMed ID: 11119809
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cytomegalovirus-associated haemophagocytic syndrome in a kidney transplant patient].
    Bea Granell S; Beneyto Castello I; Ramos Escorihuela D; Sánchez Plumed J; Sánchez Pérez P; Hernández-Jaras J; Rivas S
    Nefrologia; 2011; 31(2):236-8. PubMed ID: 21461026
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytomegalovirus infection after liver transplantation.
    Chen YS; Chen CL; Kuo YC; Sun CK
    Transplant Proc; 1994 Aug; 26(4):2229-30. PubMed ID: 8066728
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment and prevention of cytomegalovirus in renal transplant patients: weighing the evidence.
    Hakkert A; Dykeman-Sharpe J
    CANNT J; 2003; 13(3):69-73; quiz 74-5. PubMed ID: 14596201
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytomegalovirus infection and cardiac allograft vasculopathy in children.
    Webber SA
    Circulation; 2007 Apr; 115(13):1701-2. PubMed ID: 17404170
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytomegalovirus prophylaxis with intravenous polyvalent immunoglobulin in high-risk renal transplant recipients.
    Leroy F; Sechet A; Abou Ayache R; Thierry A; Belmouaz S; Desport E; Bauwens M; Bridoux F; Touchard G
    Transplant Proc; 2006 Sep; 38(7):2324-6. PubMed ID: 16980080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of cytomegalovirus infection after liver transplantation.
    Sampathkumar P; Paya CV
    Liver Transpl; 2000 Mar; 6(2):144-56. PubMed ID: 10719012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.